Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stroke

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 151 articles:
HTML format



Single Articles


    April 2021
  1. BEST JG, Ambler G, Wilson D, Lee KJ, et al
    Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from
    Lancet Neurol. 2021;20:294-303.
    PubMed     Abstract available


  2. GREENBERG SM
    Cerebral microbleeds and prediction of intracranial haemorrhage.
    Lancet Neurol. 2021;20:252-254.
    PubMed    


  3. ZIAI WC, Al-Kawaz M
    Blood pressure management after endovascular therapy.
    Lancet Neurol. 2021;20:248-249.
    PubMed    


  4. LAUMANN TO, Ortega M, Hoyt CR, Seider NA, et al
    Brain network reorganisation in an adolescent after bilateral perinatal strokes.
    Lancet Neurol. 2021;20:255-256.
    PubMed    


    March 2021
  5. ENGELTER ST, Traenka C, Gensicke H, Schaedelin SA, et al
    Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
    Lancet Neurol. 2021 Mar 22. pii: S1474-4422(21)00044.
    PubMed     Abstract available


  6. HOWARD DPJ, Gaziano L, Rothwell PM
    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.
    Lancet Neurol. 2021;20:193-202.
    PubMed     Abstract available


  7. VAN DIJCK JTJM, Kompanje EJO, Nederkoorn PJ, Peul WC, et al
    Advanced consent for acute stroke trials - Authors' reply.
    Lancet Neurol. 2021;20:170-171.
    PubMed    


  8. SHAMY M, Dewar B, Niznick N, Nicholls S, et al
    Advanced consent for acute stroke trials.
    Lancet Neurol. 2021;20:170.
    PubMed    


  9. SPENCE JD
    Treatment of asymptomatic carotid stenosis.
    Lancet Neurol. 2021;20:163-165.
    PubMed    


    February 2021
  10. MAZIGHI M, Richard S, Lapergue B, Sibon I, et al
    Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2021 Feb 26. pii: S1474-4422(20)30483.
    PubMed     Abstract available


    January 2021
  11. DUVEKOT MHC, Venema E, Rozeman AD, Moudrous W, et al
    Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30439.
    PubMed     Abstract available


  12. GOYAL M, Marko M
    Optimising prehospital stroke triage in a changing landscape.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30488.
    PubMed    


  13. TSIVGOULIS G, Katsanos AH
    Important advances in stroke research in 2020.
    Lancet Neurol. 2021;20:2-3.
    PubMed    


    December 2020
  14. WU S, Anderson CS
    Healthy eating for secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30450.
    PubMed    


  15. ENGLISH C, MacDonald-Wicks L, Patterson A, Attia J, et al
    The role of diet in secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30433.
    PubMed     Abstract available


  16. SILBERGLEIT R, Dickert NW
    Context and principles must drive alternatives to consent in emergency research.
    Lancet Neurol. 2020;19:968-969.
    PubMed    


    November 2020
  17. THE LANCET NEUROLOGY
    A unified European action plan on stroke.
    Lancet Neurol. 2020 Nov 6. pii: S1474-4422(20)30409.
    PubMed    


    October 2020
  18. MERETOJA A, Yassi N, Wu TY, Churilov L, et al
    Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2020 Oct 28. pii: S1474-4422(20)30369.
    PubMed     Abstract available


  19. KOMPANJE EJO, van Dijck JTJM, Chalos V, van den Berg SA, et al
    Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke.
    Lancet Neurol. 2020 Oct 21. pii: S1474-4422(20)30276.
    PubMed     Abstract available


    September 2020
  20. FIFI JT, Mocco J
    COVID-19 related stroke in young individuals.
    Lancet Neurol. 2020;19:713-715.
    PubMed    


    August 2020

  21. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:661-669.
    PubMed     Abstract available



  22. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:651-660.
    PubMed     Abstract available


  23. KWAKKEL G, Meskers C, Ward NS
    Time for the next stage of stroke recovery trials.
    Lancet Neurol. 2020;19:636-637.
    PubMed    


    July 2020
  24. FASSBENDER K, Walter S, Grunwald IQ, Merzou F, et al
    Prehospital stroke management in the thrombectomy era.
    Lancet Neurol. 2020;19:601-610.
    PubMed     Abstract available


  25. MOHR JP, Overbey JR, Hartmann A, Kummer RV, et al
    Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Lancet Neurol. 2020;19:573-581.
    PubMed     Abstract available


    May 2020
  26. HURFORD R, Wolters FJ, Li L, Lau KK, et al
    Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.
    Lancet Neurol. 2020;19:413-421.
    PubMed     Abstract available


  27. HERMANN DM, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Refining endpoints for stroke recovery trials.
    Lancet Neurol. 2020;19:381-382.
    PubMed    


  28. UCHIYAMA S
    Intensive medical management of intracranial arterial stenosis.
    Lancet Neurol. 2020;19:371-373.
    PubMed    


  29. THE LANCET NEUROLOGY
    The fight against stroke must go on.
    Lancet Neurol. 2020;19:369.
    PubMed    


  30. MORGAN J
    Werner Hacke: a new era for stroke patients.
    Lancet Neurol. 2020;19:387.
    PubMed    


    March 2020
  31. CHABRIAT H, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2020;19:226-233.
    PubMed     Abstract available


  32. CRAMER SC
    Issues important to the design of stroke recovery trials.
    Lancet Neurol. 2020;19:197-198.
    PubMed    


  33. GOYAL M, Ospel J
    Challenges to stroke care 5 years after endovascular therapy became the standard.
    Lancet Neurol. 2020;19:210-211.
    PubMed    


    January 2020
  34. STINEAR CM, Lang CE, Zeiler S, Byblow WD, et al
    Advances and challenges in stroke rehabilitation.
    Lancet Neurol. 2020 Jan 28. pii: S1474-4422(19)30415.
    PubMed     Abstract available


  35. WU S, Cheng Y, Wu B, Liu M, et al
    Stroke research in 2019: towards optimising treatment and prevention.
    Lancet Neurol. 2020;19:2-3.
    PubMed    


    December 2019
  36. SCHONEWILLE WJ
    BEST evidence on mechanical thrombectomy for patients with vertebrobasilar occlusion.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30477.
    PubMed    


  37. LIU X, Dai Q, Ye R, Zi W, et al
    Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30395.
    PubMed     Abstract available


    November 2019
  38. AHMADI M, Laumeier I, Ihl T, Steinicke M, et al
    A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30369.
    PubMed     Abstract available


  39. LI L
    Support programme for secondary prevention of stroke: inspiration to continue?
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30410.
    PubMed    


  40. BAYONA-ORTIZ H, Useche JN, Yanez N, Velasco SC, et al
    Availability of stroke units in Colombia.
    Lancet Neurol. 2019;18:988.
    PubMed    


    October 2019
  41. THE LANCET NEUROLOGY
    Global prevention of stroke: focus on the individual?
    Lancet Neurol. 2019;18:903.
    PubMed    


    September 2019
  42. MOULLAALI TJ, Wang X, Martin RH, Shipes VB, et al
    Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
    Lancet Neurol. 2019;18:857-864.
    PubMed     Abstract available


  43. FLOEL A
    Computerised speech and language therapy in post-stroke aphasia.
    Lancet Neurol. 2019;18:806-807.
    PubMed    


  44. PALMER R, Dimairo M, Cooper C, Enderby P, et al
    Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Lancet Neurol. 2019;18:821-833.
    PubMed     Abstract available


    July 2019
  45. SHI K, Tian DC, Li ZG, Ducruet AF, et al
    Global brain inflammation in stroke.
    Lancet Neurol. 2019 Jul 8. pii: S1474-4422(19)30078.
    PubMed     Abstract available


  46. SAPOSNIK G, Hachinski V
    The pathway towards an effective reduction of stroke burden worldwide: teamwork.
    Lancet Neurol. 2019;18:622-623.
    PubMed    


    June 2019
  47. TOYODA K, Uchiyama S, Yamaguchi T, Easton JD, et al
    Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2019;18:539-548.
    PubMed     Abstract available


  48. HILL MD, Benavente OR
    The uncertain role for phosphodiesterase inhibitors in stroke prevention.
    Lancet Neurol. 2019;18:515-517.
    PubMed    


  49. STINEAR CM
    Dopamine for motor recovery after stroke: where to from here?
    Lancet Neurol. 2019;18:514-515.
    PubMed    


  50. FORD GA, Bhakta BB, Cozens A, Hartley S, et al
    Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2019;18:530-538.
    PubMed     Abstract available


  51. THE LANCET NEUROLOGY
    Adding stroke to the political agenda in Europe.
    Lancet Neurol. 2019;18:513.
    PubMed    


    May 2019
  52. WILSON D, Ambler G, Lee KJ, Lim JS, et al
    Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30197.
    PubMed     Abstract available


  53. TSIVGOULIS G, Katsanos AH
    Can cerebral microbleeds predict stroke recurrence?
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30194.
    PubMed    


  54. AL-SHAHI SALMAN R, Minks DP, Mitra D, Rodrigues MA, et al
    Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30184.
    PubMed     Abstract available


  55. CHRISTENSEN H
    Antiplatelets after intracerebral haemorrhage: treat the patient, not the brain imaging.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30189.
    PubMed    


    April 2019
  56. OURIQUES MARTINS SC, Sacks C, Hacke W, Brainin M, et al
    Priorities to reduce the burden of stroke in Latin American countries.
    Lancet Neurol. 2019 Apr 24. pii: S1474-4422(19)30068.
    PubMed     Abstract available


  57. DICHGANS M, Pulit SL, Rosand J
    Stroke genetics: discovery, biology, and clinical applications.
    Lancet Neurol. 2019 Apr 8. pii: S1474-4422(19)30043.
    PubMed     Abstract available


  58. SABA L, Saam T, Jager HR, Yuan C, et al
    Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications.
    Lancet Neurol. 2019 Apr 3. pii: S1474-4422(19)30035.
    PubMed     Abstract available


  59. ALEXANDROV AV, Kohrmann M, Soinne L, Tsivgoulis G, et al
    Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
    Lancet Neurol. 2019;18:338-347.
    PubMed     Abstract available


  60. GAUBERTI M
    Reperfusion in acute ischaemic stroke by sonothrombolysis.
    Lancet Neurol. 2019;18:320-321.
    PubMed    


  61. BRAININ M
    Stroke epidemiology in China: which are the next steps?
    Lancet Neurol. 2019;18:325-326.
    PubMed    


  62. WU S, Wu B, Liu M, Chen Z, et al
    Stroke in China: advances and challenges in epidemiology, prevention, and management.
    Lancet Neurol. 2019;18:394-405.
    PubMed     Abstract available


    March 2019

  63. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30034.
    PubMed     Abstract available


  64. GORELICK PB
    The global burden of stroke: persistent and disabling.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30030.
    PubMed    


  65. OGAWA A, Toyoda K, Kitagawa K, Kitazono T, et al
    Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
    Lancet Neurol. 2019;18:238-247.
    PubMed     Abstract available


  66. MELIS M, Ricci S, Toni D
    Optimal stroke prevention in patients with PFO.
    Lancet Neurol. 2019;18:231.
    PubMed    


  67. DICHGANS M
    Dementia risk after transient ischaemic attack and stroke.
    Lancet Neurol. 2019;18:223-225.
    PubMed    


  68. HANKEY GJ
    Prasugrel or clopidogrel for long-term secondary stroke prevention?
    Lancet Neurol. 2019;18:222-223.
    PubMed    


  69. PENDLEBURY ST, Rothwell PM
    Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
    Lancet Neurol. 2019;18:248-258.
    PubMed     Abstract available


    February 2019
  70. BROTT TG, Calvet D, Howard G, Gregson J, et al
    Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data.
    Lancet Neurol. 2019 Feb 6. pii: S1474-4422(19)30028.
    PubMed     Abstract available


    January 2019
  71. WARDLAW JM, Bath PM
    Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets.
    Lancet Neurol. 2019;18:2-3.
    PubMed    


    December 2018
  72. THIEBAUT AM, Gauberti M, Ali C, Martinez De Lizarrondo S, et al
    The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
    Lancet Neurol. 2018;17:1121-1132.
    PubMed     Abstract available


  73. SCHEITZ JF, Nolte CH, Doehner W, Hachinski V, et al
    Stroke-heart syndrome: clinical presentation and underlying mechanisms.
    Lancet Neurol. 2018;17:1109-1120.
    PubMed     Abstract available


    November 2018
  74. SEIFFGE DJ, Werring DJ, Paciaroni M, Dawson J, et al
    Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
    Lancet Neurol. 2018 Nov 8. pii: S1474-4422(18)30356.
    PubMed     Abstract available


  75. CAMPBELL BCV, Majoie CBLM, Albers GW, Menon BK, et al
    Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30314.
    PubMed     Abstract available


  76. WARACH S
    Patients with large brain infarcts might also benefit from thrombectomy.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30357.
    PubMed    


    October 2018
  77. MEIER B
    Optimal stroke prevention in patients with patent foramen ovale.
    Lancet Neurol. 2018 Oct 16. pii: S1474-4422(18)30369.
    PubMed    


  78. ROMAN LS, Menon BK, Blasco J, Hernandez-Perez M, et al
    Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018;17:895-904.
    PubMed     Abstract available


  79. BROWN MM, Bonati LH
    The fate of severe restenosis after carotid interventions - Authors' reply.
    Lancet Neurol. 2018;17:843-844.
    PubMed    


  80. ALBERS GW
    Endovascular thrombectomy in patients with large infarctions: reasons for restraint.
    Lancet Neurol. 2018;17:836-837.
    PubMed    


    September 2018
  81. KASNER SE, Swaminathan B, Lavados P, Sharma M, et al
    Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Lancet Neurol. 2018 Sep 28. pii: S1474-4422(18)30319.
    PubMed     Abstract available


  82. EKKER MS, Boot EM, Singhal AB, Tan KS, et al
    Epidemiology, aetiology, and management of ischaemic stroke in young adults.
    Lancet Neurol. 2018;17:790-801.
    PubMed     Abstract available


  83. LIU T, Ding Y, Wen A
    Traditional Chinese medicine for ischaemic stroke.
    Lancet Neurol. 2018;17:745.
    PubMed    


    August 2018
  84. DENNIS M
    Pharyngeal stimulation after stroke: more evidence is needed.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30312.
    PubMed    


  85. DZIEWAS R, Stellato R, van der Tweel I, Walther E, et al
    Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30255.
    PubMed     Abstract available


  86. AL-SHAHI SALMAN R, Frantzias J, Lee RJ, Lyden PD, et al
    Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.
    Lancet Neurol. 2018 Aug 14. pii: S1474-4422(18)30253.
    PubMed     Abstract available


  87. WOO D, Anderson CD, Maguire J, Fornage M, et al
    Top research priorities for stroke genetics.
    Lancet Neurol. 2018;17:663-665.
    PubMed    


    July 2018
  88. BUSHNELL C, Howard VJ, Lisabeth L, Caso V, et al
    Sex differences in the evaluation and treatment of acute ischaemic stroke.
    Lancet Neurol. 2018;17:641-650.
    PubMed     Abstract available


  89. CHATURVEDI S
    Is surveillance for restenosis justified after carotid revascularisation?
    Lancet Neurol. 2018;17:570-571.
    PubMed    


    June 2018
  90. MORGAN J
    A new life after stroke.
    Lancet Neurol. 2018 Jun 25. pii: S1474-4422(18)30249.
    PubMed    


  91. MAZZUCCO S, Li L, Binney L, Rothwell PM, et al
    Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30167.
    PubMed     Abstract available


  92. QUADRI M, Mandemakers W, Grochowska MM, Masius R, et al
    LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30179.
    PubMed     Abstract available


  93. THALER D
    Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30198.
    PubMed    


  94. WILSON D, Ambler G, Shakeshaft C, Brown MM, et al
    Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
    Lancet Neurol. 2018;17:539-547.
    PubMed     Abstract available


  95. KIM BJ, Lee EJ, Kwon SU, Park JH, et al
    Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
    Lancet Neurol. 2018;17:509-518.
    PubMed     Abstract available


  96. CORDONNIER C
    Balancing risks versus benefits of anticoagulants in stroke prevention.
    Lancet Neurol. 2018;17:487-488.
    PubMed    


  97. AL-SHAHI SALMAN R
    A new era for comorbid cerebral ischaemia and haemorrhage.
    Lancet Neurol. 2018;17:482-483.
    PubMed    


  98. THE LANCET NEUROLOGY
    Strong alliances to improve stroke care.
    Lancet Neurol. 2018;17:481.
    PubMed    


    May 2018
  99. BONATI LH, Gregson J, Dobson J, McCabe DJH, et al
    Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial.
    Lancet Neurol. 2018 May 31. pii: S1474-4422(18)30195.
    PubMed     Abstract available


  100. SCHWAMM LH
    Disruptive innovation in acute stroke systems of care.
    Lancet Neurol. 2018 May 25. pii: S1474-4422(18)30197.
    PubMed    


    April 2018
  101. ROTHWELL PM
    Clinical innovation in stroke: getting the simple things right.
    Lancet Neurol. 2018 Apr 10. pii: S1474-4422(18)30113.
    PubMed    



  102. Yogeshwar Kalkonde.
    Lancet Neurol. 2018;17:305.
    PubMed    


  103. CHARLIER P, Appenzeller O, Deo S, Perciaccante A, et al
    Hemiplegic migraine and stroke in Mary Shelley.
    Lancet Neurol. 2018;17:305.
    PubMed    


    February 2018
  104. GALOVIC M, Dohler N, Keezer MR, Duncan JS, et al
    The SeLECT score is useful to predict post-stroke epilepsy.
    Lancet Neurol. 2018 Feb 15. pii: S1474-4422(18)30075.
    PubMed    


  105. GALOVIC M, Dohler N, Erdelyi-Canavese B, Felbecker A, et al
    Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study.
    Lancet Neurol. 2018;17:143-152.
    PubMed     Abstract available


  106. FINSTERER J
    The SeLECT score is inappropriate to predict post-stroke epilepsy.
    Lancet Neurol. 2018;17:106-107.
    PubMed    


    January 2018
  107. RODRIGUES MA, Samarasekera N, Lerpiniere C, Humphreys C, et al
    The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.
    Lancet Neurol. 2018 Jan 10. pii: S1474-4422(18)30006.
    PubMed     Abstract available


  108. CAMPBELL BCV, van Zwam WH, Goyal M, Menon BK, et al
    Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.
    Lancet Neurol. 2018;17:47-53.
    PubMed     Abstract available


  109. DINSMORE J
    HERMES: a helpful messenger in the anaesthesia for thrombectomy debate?
    Lancet Neurol. 2018;17:21-23.
    PubMed    


    November 2017
  110. CORLEY J
    Telestroke: India's solution to a public health-care crisis.
    Lancet Neurol. 2017 Nov 29. pii: S1474-4422(17)30423.
    PubMed    


  111. BURTON A
    Trying to change the stroke landscape in Nigeria.
    Lancet Neurol. 2017;16:869-870.
    PubMed    


    October 2017
  112. STINEAR CM
    Prediction of motor recovery after stroke: advances in biomarkers.
    Lancet Neurol. 2017;16:826-836.
    PubMed     Abstract available


  113. WILSON L, Stewart W, Dams-O'Connor K, Diaz-Arrastia R, et al
    The chronic and evolving neurological consequences of traumatic brain injury.
    Lancet Neurol. 2017;16:813-825.
    PubMed     Abstract available


  114. PLOUGHMAN M
    A new era of multiple sclerosis rehabilitation: lessons from stroke.
    Lancet Neurol. 2017;16:768-769.
    PubMed    


    September 2017
  115. FINSTERER J
    Low risk of ischaemic stroke in hyperhomocysteinaemia.
    Lancet Neurol. 2017;16:682-683.
    PubMed    


  116. SPENCE JD, Yi Q, Hankey GJ
    B vitamins in stroke prevention: time to reconsider.
    Lancet Neurol. 2017;16:750-760.
    PubMed     Abstract available


  117. VAN VELUW SJ, Shih AY, Smith EE, Chen C, et al
    Detection, risk factors, and functional consequences of cerebral microinfarcts.
    Lancet Neurol. 2017;16:730-740.
    PubMed     Abstract available


    August 2017
  118. ANDERSON CS
    NOR-TEST-ing tenecteplase in acute ischaemic stroke.
    Lancet Neurol. 2017 Aug 8. pii: S1474-4422(17)30277.
    PubMed    


  119. LOGALLO N, Novotny V, Assmus J, Kvistad CE, et al
    Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Lancet Neurol. 2017 Aug 2. pii: S1474-4422(17)30253.
    PubMed     Abstract available


  120. MAEGELE M, Schochl H, Menovsky T, Marechal H, et al
    Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management.
    Lancet Neurol. 2017;16:630-647.
    PubMed     Abstract available


  121. SIHVONEN AJ, Sarkamo T, Leo V, Tervaniemi M, et al
    Music-based interventions in neurological rehabilitation.
    Lancet Neurol. 2017;16:648-660.
    PubMed     Abstract available


    July 2017
  122. WACHTER R, Groschel K
    Atrial fibrillation in high-risk patients with ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:498.
    PubMed    


  123. KNECHT S, Petsch S, Studer B
    Atrial fibrillation in high-risk patients with ischaemic stroke.
    Lancet Neurol. 2017;16:498.
    PubMed    


    May 2017
  124. BERGE E, Salman RA, van der Worp HB, Stapf C, et al
    Increasing value and reducing waste in stroke research.
    Lancet Neurol. 2017;16:399-408.
    PubMed     Abstract available


    March 2017
  125. HESS DC, Wechsler LR, Clark WM, Savitz SI, et al
    Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2017 Mar 17. pii: S1474-4422(17)30046.
    PubMed     Abstract available


  126. DAVALOS A, Cobo E, Molina CA, Chamorro A, et al
    Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
    Lancet Neurol. 2017 Mar 16. pii: S1474-4422(17)30047.
    PubMed     Abstract available


  127. FASSBENDER K, Grotta JC, Walter S, Grunwald IQ, et al
    Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.
    Lancet Neurol. 2017;16:227-237.
    PubMed     Abstract available


  128. ELKINS J, Veltkamp R, Montaner J, Johnston SC, et al
    Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Lancet Neurol. 2017;16:217-226.
    PubMed     Abstract available


  129. TATLISUMAK T
    Can natalizumab be beneficial in acute ischaemic stroke?
    Lancet Neurol. 2017;16:176-177.
    PubMed    


    February 2017
  130. AMARENCO P, Albers GW, Denison H, Easton JD, et al
    Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Feb 23. pii: S1474-4422(17)30038.
    PubMed     Abstract available


  131. WACHTER R, Groschel K, Gelbrich G, Hamann GF, et al
    Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
    Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002.
    PubMed     Abstract available


  132. BRACARD S, Ducrocq X, Guillemin F, Moulin T, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:104.
    PubMed    


  133. BADHIWALA JH, Nassiri F, Kulkarni AV, Spears J, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103.
    PubMed    


  134. MORELLI N, Rota E, Michieletti E, Guidetti D, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103-104.
    PubMed    


    November 2016
  135. KELLY PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, et al
    Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
    Lancet Neurol. 2016;15:1238-1247.
    PubMed     Abstract available


  136. HANLEY DF, Thompson RE, Muschelli J, Rosenblum M, et al
    Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
    Lancet Neurol. 2016;15:1228-1237.
    PubMed     Abstract available


  137. KIM AS
    Stroke risk prediction after transient ischaemic attack.
    Lancet Neurol. 2016;15:1199-1200.
    PubMed    


    October 2016
  138. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Abstract available


    August 2016
  139. BERKHEMER OA, Dippel DW
    Intra-arterial therapy for acute ischaemic stroke.
    Lancet Neurol. 2016 Aug 23. pii: S1474-4422(16)30197.
    PubMed    


  140. THE LANCET NEUROLOGY
    The shared burden of stroke and dementia.
    Lancet Neurol. 2016;15:891.
    PubMed    


    July 2016
  141. SEITZ RJ
    The pros and cons of intravenous thrombolysis in stroke.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30159.
    PubMed    


  142. RUDD AG
    Can emergency stroke care be delivered in an ambulance?
    Lancet Neurol. 2016 Jul 15. pii: S1474-4422(16)30162.
    PubMed    


  143. FRASER JF
    Standardisation of research strategies in acute ischaemic stroke.
    Lancet Neurol. 2016;15:784-5.
    PubMed    


  144. AL-SHAHI SALMAN R, McGoohan K, Rodrigues M, Dichgans M, et al
    Dementia after stroke due to intracerebral haemorrhage.
    Lancet Neurol. 2016;15:779-80.
    PubMed    


    June 2016
  145. SILVER B
    Virtual reality versus reality in post-stroke rehabilitation.
    Lancet Neurol. 2016 Jun 27. pii: S1474-4422(16)30126.
    PubMed    


  146. HACHINSKI V, Azarpazhooh MR
    Stroke is a burdensome but preventable brain disorder.
    Lancet Neurol. 2016 Jun 9. pii: S1474-4422(16)30120.
    PubMed    


  147. KIECHL S, Willeit J
    Alteplase in acute ischaemic stroke: no time to slow down.
    Lancet Neurol. 2016 Jun 8. pii: S1474-4422(16)30095.
    PubMed    


  148. HACHINSKI V, Sposato LA, Kapral M
    Preventing both stroke and dementia.
    Lancet Neurol. 2016;15:659.
    PubMed    


  149. BRAYNE C, Wu YT
    Preventing both stroke and dementia - Authors' reply.
    Lancet Neurol. 2016;15:659.
    PubMed    


  150. VON KUMMER R
    Early CT Score to establish stroke treatment.
    Lancet Neurol. 2016;15:651-3.
    PubMed    


  151. CORALLI A, Perciaccante A
    Leonardo's recurrent stroke?
    Lancet Neurol. 2016;15:667.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: